A carregar...
Publicação
Cutaneous manifestations associated with SARS-CoV-2: an emerging topic in a pandemic era
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.53 MB | Adobe PDF |
Orientador(es)
Resumo(s)
A 70-year-old man was admitted to our COVID-19 ward with thoracalgia, productive mucus cough, fatigue and
erythematous–violaceous macules on the inner side of feet and interdigital regions. The patient was started on
oxygen and dexamethasone. On the day of discharge, he maintained the skin changes despite the resolution
of COVID-19 symptoms. A 57-year-old woman initially presented with diffuse urticarial rash on the cervical and
chest region. Oral cetirizine was started, and pruritus improved. Thirty days after the discharge, the patient
maintained the rash, but without pruritus. A 49-year-old man was admitted with thoracalgia, shortness of
breath, dry cough and urticarial rash on the cervical and chest region. The patient was treated with cetirizine.
The pruritus improved, and 5 days after discharge, the urticarial areas completely disappeared.
Descrição
Palavras-chave
SARS-CoV-2- cutaneous manifestations hydroxychloroquine COVID-19-Treatment treatment recommendations Medeira Island Região Autónoma da Madeira diffuse urticarial rash oral citirizine
Contexto Educativo
Citação
Luís H, et al. BMJ Case Rep 2021;14:e244763. doi:10.1136/bcr-2021-244763
Editora
BMJ Publishing Group Limited